Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: Per-Operative Radiotherapy by Papillon +TM in Localized Breast Cancer [Phase 2]
Phase 2 trial evaluating Papillon+TM per-operative radiotherapy for localized breast cancer is currently recruiting at Centre Antoine Lacass…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: IORT-Breast at Medical Center Navicent Health
Update on the IORT-Breast trial at Medical Center Navicent Health, sponsored by Wake Forest University Health Sciences; the study targets br…
-
EMA approval · 2026-01-28EMA Authorised: Abevmy (bevacizumab) — Biosimilar Collaborations Ireland Limited
EMA authorised Abevmy (bevacizumab) as a biosimilar. It is approved for several cancer indications including colorectal, breast, ovarian, fa…
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Fulvestrant and Ipatasertib for Advanced HER-2 Negative and Estrogen Receptor Positive (ER+) Breast Cancer Following Progression on First Line CDK 4/6 Inhibitor and Aromatase Inhibitor [Phase 3]
A Phase 3 trial evaluating the combination of fulvestrant and ipatasertib in advanced ER-positive, HER2-negative breast cancer after progres…
-
EMA approval · 2026-01-28EMA Authorised: Oyavas (bevacizumab) — STADA Arzneimittel AG
EMA authorised Oyavas, a bevacizumab biosimilar by STADA, for multiple indications including colorectal, breast, ovarian, fallopian tube, pe…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: No Axillary Surgical Treatment in Clinically Lymph Node Negative Patients on Ultrasonography After Neoadjuvant Chemotherapy [Phase 3]
Phase 3 clinical trial evaluating omission of axillary surgery in clinically node-negative breast cancer patients after neoadjuvant chemothe…
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Evaluation of Lasofoxifene Versus Fulvestrant in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation [Phase 2]
Phase 2 trial comparing lasofoxifene to fulvestrant in advanced or metastatic ER+/HER2- breast cancer with ESR1 mutation has completed.
-
EMA approval · 2026-01-28EMA Authorised: Vegzelma (bevacizumab) — Celltrion Healthcare Hungary Kft.
EMA authorised Vegzelma, a bevacizumab biosimilar from Celltrion Healthcare Hungary Kft., for multiple cancers including colorectal, breast,…
-
EMA approval · 2026-01-28EMA Authorised: Aybintio (bevacizumab) — Samsung Bioepis NL B.V.
The EMA authorised Aybintio, a bevacizumab biosimilar from Samsung Bioepis NL B.V., for multiple cancer indications including colorectal, br…
-
EMA approval · 2026-01-28EMA Authorised: Herzuma (trastuzumab) — Celltrion Healthcare Hungary Kft.
The EMA authorised Herzuma, a trastuzumab biosimilar from Celltrion Healthcare Hungary Kft, for stomach cancer and breast cancer in the EU.
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, HR+/HER2- Breast Cancer [Phase 1]
This clinical trial is evaluating ribociclib given concurrently with postoperative radiation therapy in patients with high-risk HR+/HER2- br…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Creatine and Cognitive Health in Patients With Early-stage Breast Cancer During and After Chemotherapy Treatment [Phase 3]
A Phase 3 clinical trial evaluating whether creatine improves cognitive health in patients with early-stage breast cancer during and after c…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Adding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic Women
A Mayo Clinic-backed clinical trial is evaluating the addition of a genetic risk evaluation to standard breast cancer risk assessment specif…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors [NA]
Duke University is recruiting for a study on symptom management and transitioning to engagement with post-treatment care for adolescent and …
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: TME Alteration in HER2 Positive Breast Cancer
This clinical trial update describes research on altering the tumor microenvironment in HER2-positive breast cancer.
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating cemiplimab in combination with transarterial radioembolization using Y-90 SIR-Spheres for liver-directed…
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Fluorizoparib Plus Apatinib Versus Chemotherapy in HRD-positive, HER2-negative Advanced Breast Cancer [Phase 3]
Phase 3 trial evaluating fluorizoparib plus apatinib versus chemotherapy in HRD-positive/HER2-negative metastatic breast cancer; the study i…
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Sexual Health in Breast Cancer Patients
Completed clinical trial evaluating sexual health in breast cancer patients; sponsored by the University of Colorado, Denver.
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors [Phase 2]
Phase 2 trial update for HER3-DXd in locally advanced or metastatic solid tumors; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Continuous Positive Airway Pressure (CPAP) Assisted Radiotherapy in Breast Cancer [Phase 2, Phase 3]
Phase 2/3 trial evaluating CPAP-assisted radiotherapy for early-stage breast cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Molecular Mechanisms of Clinical Resistance to Targeted Therapy Among Patients With Breast Cancer
A completed clinical trial investigating the molecular mechanisms underlying resistance to targeted therapy in patients with breast cancer.
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Effect of Continuous Intraoperative Esketamine Infusion on Perioperative Negative Emotions in Breast Cancer Surgery Patients With Mild-to-Severe Depression [NA]
This clinical trial investigates whether continuous intraoperative esketamine infusion can reduce perioperative negative emotions in patient…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Sequencing SG vs. T-DXd in HER2-Low/TROP2-High Metastatic Breast Cancer [Phase 2]
Clinical trial update for a Phase 2 study comparing sequencing Sacituzumab Govitecan (SG) versus Trastuzumab Deruxtecan (T-DXd) in HER2-low/…
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Study of Sacituzumab Govitecan With Atropine to Improve Tolerability in Advanced TNBC and HR+/HER2- Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating sacituzumab govitecan in combination with atropine to improve tolerability in advanced breast cancers, i…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy [Phase 2]
Phase 2 clinical trial comparing Replens vaginal moisturizer to intra-vaginal estrogen for vaginal dryness in patients with estrogen recepto…